EBOS Group Ltd (EBO)

New Zealand
Currency in NZD
41.91
+0.42(+1.01%)
Delayed Data
EBO Scorecard
Full Analysis
Has raised its dividend for 11 consecutive years
Fair Value
Day's Range
41.1042.00
52 wk Range
31.0242.55
Key Statistics
Edit
Bid/Ask
41.90 / 41.91
Prev. Close
41.49
Open
41.1
Day's Range
41.1-42
52 wk Range
31.02-42.55
Volume
45.66K
Average Volume (3m)
96.17K
1-Year Change
14.27%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EBO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
39.48
Downside
-5.80%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

EBOS Group Ltd Company Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Employees
4557

Compare EBO to Peers and Sector

Metrics to compare
EBO
Peers
Sector
Relationship
P/E Ratio
26.7x7.4x−0.7x
PEG Ratio
4.270.020.00
Price/Book
3.0x1.8x2.6x
Price / LTM Sales
0.5x1.5x3.1x
Upside (Analyst Target)
−3.8%15.9%47.6%
Fair Value Upside
Unlock12.6%7.7%Unlock

Analyst Ratings

4 Buy
3 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 39.48
(-5.80% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.41
Dividend Yield
2.96%
Industry Median 3.59%
Annualised payout
1.2373
Paid unevenly
5-Years Growth
+10.00%
Growth Streak

Earnings

Latest Release
Feb 14, 2023
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the EBOS (EBO) Stock Price Today?

The EBOS stock price today is 41.91

What Stock Exchange Does EBOS Trade On?

EBOS is listed and trades on the New Zealand stock exchange.

What Is the Stock Symbol for EBOS?

The stock symbol for EBOS is "EBO."

Does EBOS Pay Dividends? What’s The Current Dividend Yield?

The EBOS dividend yield is 2.96%.

What Is the EBOS Market Cap?

As of today, EBOS market cap is 8.17B.

What is EBOS Earnings Per Share?

The EBOS EPS is 1.41.

From a Technical Analysis Perspective, Is EBO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.